Treos Bio Limited, which is developing personal cancer vaccines combined with companion diagnostic devices, reported updated positive results on the second part of its phase 1/2 study (OBERTO) with the PolyPEPI1018 cancer vaccine as an add-on to maintenance therapy in...
89bio, Inc. (89bio or the company), a clinical-stage biopharmaceutical company, has initiated dosing in its proof of concept Phase 1b/2a clinical trial evaluating its product candidate, BIO89-100, in patients with nonalcoholic steatohepatitis (NASH) or patients with...
ImaginAb Inc., a clinical-stage immuno-oncology imaging company, today announces it has enrolled its first patient for the Phase II clinical trial of its lead product CD8 tracer, 89Zr-Df-IAB22M2C, at the O’Neal Comprehensive Cancer Center at the University of...
BMN 307 Represents a Potential 3rd PKU Treatment Option in BioMarin’s PKU Franchise 2nd Gene Therapy Program in Product Pipeline BioMarin Pharmaceutical Inc. (Nasdaq:BMRN), a pioneer in treatments for rare disease Phenylketonuria (PKU) and in gene therapies,...
In the digital age, Search Engine Optimization (SEO) provides companies with ample opportunity to increase business. If a business is not utilizing SEO, they are doing themselves a disservice. For example, for a clinical trials recruitment agency, SEO provides the...
Email
Text